bso cancer treatment glutathione Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Buthionine sulfoximine, an inhibitor of

Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE

SKU: 32589900070 · From centoria.fr